Jump to
The Parker lab focuses on assay development for post-translational modifications, with an emphasis on protein phosphorylation by tyrosine kinases. Our team uses chemical biology and proteomics to develop tests to quickly screen for better inhibitor drugs, and/or determine effectiveness of inhibitors to improve patient outcomes during cancer treatment.